Abstract: This article explored practical management experience of in vitro diagnostic reagents, continuously improved the informatization of in vitro diagnostic reagents and carried out cost-benefit analysis further, through studying "in vitro diagnostic reagents Registration" issued by China Food and Drug Administration in 2014. So that we achieved a unified centralized management of in vitro diagnostic reagents, improved the working efficiency and provided patients with more accurate and efficient service.